University of Missouri — Columbus, Colorado

Public research footprint of University of Missouri, compiled from the ClinicalTrials.gov public registry.

371

Registered studies

Active

Recruiting now

234

Completed

Stopped or withdrawn

Most-studied conditions

Botryoid-Type Embryonal Rhabdomyosarcoma · Spindle Cell Rhabdomyosarcoma · B Acute Lymphoblastic Leukemia · B Lymphoblastic Lymphoma

Recently updated registry entries

NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)
NCT05407636 — Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD (Active Not Recruiting)
NCT02567435 — Combination Chemotherapy With or Without Temsirolimus in Treating Patients With… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Missouri?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.